1. HDFC Bank (HDFCBANK): Shares of HDFC Bank rose by 1.70% to ₹1,797.40 on April 2, outperforming the BSE SENSEX Index, which increased by 0.78%. Despite this gain, the stock remains 4.39% below its 52-week high of ₹1,880.00, reached on December 9, 2024.

2. Tata Consultancy Services (TCS): TCS shares declined slightly by 0.15% to ₹3,545.00 on April 2, underperforming the broader market. The stock is currently 22.70% below its 52-week high of ₹4,585.90, achieved on September 2, 2024. 

3. Maruti Suzuki India (MARUTI): The company's stock gained 2.09% to close at ₹11,715.05 on April 2, surpassing some competitors. However, it remains 14.33% below its 52-week high of ₹13,675.00, recorded on August 1, 2024. ​

4. Bharat Electronics Limited (BEL): BEL secured a ₹593.22 crore contract from the Indian Air Force for the comprehensive maintenance of the Akash Missile System. This development positions the stock favorably in the defense sector. ​

5. Punjab National Bank (PNB): PNB reported strong growth for Q4, with its global business showing healthy expansion both quarterly and annually, primarily due to increases in deposits and advances. ​

6. Infosys (INFY): As a major player in the IT sector, Infosys' performance is crucial, especially amid concerns over U.S. tariffs and their potential impact on the industry. ​

7. Dabur India (DABUR): Dabur is among the stocks in focus due to recent developments in the consumer goods sector. Investors should monitor this stock for potential opportunities.

8. Siemens (SIEMENS): Siemens shares have risen on robust trading volumes, making it a stock to watch in the industrial sector. ​

9. Solar Industries India (SOLARINDS): The stock has gained attention due to increased trading volumes, reflecting positive sentiment in the market. ​

10. Mahindra Lifespace Developers (MAHLIFE): The company secured two housing redevelopment projects in Mumbai, with an expected revenue of ₹1,200 crore, positioning it favorably in the real estate sector. ​

Source: Taken from multiple websites.

Disclaimer
The information provided in this media release is based on current facts and circumstances as of the date of publication. It may contain forward-looking statements, including but not limited to projections, expectations, or assumptions about future events or performance. These forward-looking statements are subject to risks, uncertainties, and other factors that may cause actual results to differ materially from those anticipated. Hester Biosciences Ltd does not undertake any obligation to update, revise, or correct any forward-looking statements based on new information or future events. This release is intended for informational purposes only and does not constitute financial, investment, or professional advice.